» Authors » Aaron M Harris

Aaron M Harris

Explore the profile of Aaron M Harris including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 63
Citations 2178
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Said S, Shadaker S, McMahon B, Armstrong P, Beckett G, Kamili S, et al.
J Viral Hepat . 2024 Dec; 32(1):e14051. PMID: 39707980
Zanzibar, a low-resource semiautonomous region of Tanzania, has an estimated prevalence of hepatitis B virus (HBV) infections of 3.6%. To assess the feasibility of care and treatment, a 5-year hepatitis...
2.
Rainey J, Lin X, Murphy S, Velazquez-Kronen R, Do T, Hughes C, et al.
PLoS One . 2024 Apr; 19(4):e0300175. PMID: 38603766
Timely case notifications following the introduction of an uncommon pathogen, such as mpox, are critical for understanding disease transmission and for developing and implementing effective mitigation strategies. When Massachusetts public...
3.
Spradling P, Bocour A, Kuncio D, Ly K, Harris A, Thompson N
Public Health Rep . 2024 Jan; :333549231218277. PMID: 38205796
The application of a care continuum model (CCM) can identify gaps in diagnosis, care, and treatment of populations with a common condition, but challenges are inherent in developing a CCM...
4.
Bruden D, McMahon B, Snowball M, Towshend-Bulson L, Homan C, Johnston J, et al.
Hepatology . 2023 Nov; 79(6):1412-1420. PMID: 37939079
Background And Aims: A functional cure and therapeutic end point of chronic HBV infection is defined as the clearance of HBsAg from serum. Little is known about the long-term durability...
5.
Conners E, Panagiotakopoulos L, Hofmeister M, Spradling P, Hagan L, Harris A, et al.
MMWR Recomm Rep . 2023 Mar; 72(1):1-25. PMID: 36893044
Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality. Although treatment is not considered curative, antiviral treatment, monitoring, and liver cancer surveillance can reduce morbidity and...
6.
Kompaniyets L, Wiegand R, Oyalowo A, Bull-Otterson L, Egwuogu H, Thompson T, et al.
Clin Infect Dis . 2023 Feb; 76(10):1753-1760. PMID: 36750643
Background: Small sample sizes have limited prior studies' ability to capture severe COVID-19 outcomes, especially among Ad26.COV2.S vaccine recipients. This study of 18.9 million adults aged ≥18 years assessed relative...
7.
Huang Y, Yusuf H, Adamski A, Hsu J, Baggs J, Auf R, et al.
J Thromb Thrombolysis . 2022 Dec; 55(1):189-194. PMID: 36515793
The association between thromboembolic events (TE) and COVID-19 infection is not completely understood at the population level in the United States. We examined their association using a large US healthcare...
8.
Adjei S, Hong K, Molinari N, Bull-Otterson L, Ajani U, Gundlapalli A, et al.
MMWR Morb Mortal Wkly Rep . 2022 Sep; 71(37):1182-1189. PMID: 36107788
The risk for COVID-19-associated mortality increases with age, disability, and underlying medical conditions (1). Early in the emergence of the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, mortality...
9.
Kazakova S, Baggs J, Parra G, Yusuf H, Romano S, Ko J, et al.
J Hosp Med . 2022 Aug; 17(12):984-989. PMID: 36039477
The disruptions of the coronavirus disease 2019 (COVID-19) pandemic impacted the delivery and utilization of healthcare services with potential long-term implications for population health and the hospital workforce. Using electronic...
10.
Neri A, Whitfield G, Umeakunne E, Hall J, DeFrances C, Shah A, et al.
J Public Health Manag Pract . 2022 Aug; 28(6):650-656. PMID: 36037509
Telehealth is the use of electronic information and telecommunication technologies to provide care when the patient and the provider are not in the same room at the same time. Telehealth...